<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">clinical </span>
   <span class="font30">respiratory </span>
   <span class="font23">COVID- </span>
   <span class="font21">case </span>
   <span class="font18">treatment </span>
   <span class="font17">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font16">tablets, </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">infection </span>
   <span class="font16">severe </span>
   <span class="font16">coronavirus </span>
   <span class="font16">daily </span>
   <span class="font15">tablet </span>
   <span class="font15">SARS-CoV- </span>
   <span class="font15">blood </span>
   <span class="font15">chloroquine </span>
   <span class="font15">days </span>
   <span class="font15">patients </span>
   <span class="font15">performed </span>
   <span class="font14">(e.g. </span>
   <span class="font14">and/or </span>
   <span class="font14">lung </span>
   <span class="font14">ARDS </span>
   <span class="font14">Available </span>
   <span class="font14">affected </span>
   <span class="font14">days, </span>
   <span class="font14">hours </span>
   <span class="font14">symptoms </span>
   <span class="font14">worsening </span>
   <span class="font13">&amp;lt; </span>
   <span class="font13">TCZ </span>
   <span class="font13">care </span>
   <span class="font13">collab: </span>
   <span class="font13">failure </span>
   <span class="font13">novel </span>
   <span class="font13">possible </span>
   <span class="font13">February </span>
   <span class="font13">antiviral </span>
   <span class="font13">based </span>
   <span class="font13">data </span>
   <span class="font13">detection </span>
   <span class="font13">disease </span>
   <span class="font13">followed </span>
   <span class="font13">intensive </span>
   <span class="font13">management </span>
   <span class="font13">signs </span>
   <span class="font13">viral </span>
   <span class="font13">Chest </span>
   <span class="font13">National </span>
   <span class="font13">acute </span>
   <span class="font13">available </span>
   <span class="font13">dose </span>
   <span class="font13">efficacy </span>
   <span class="font13">gas </span>
   <span class="font13">levels </span>
   <span class="font13">lopinavir/ritonavir </span>
   <span class="font13">monitoring: </span>
   <span class="font13">px; </span>
   <span class="font13">remdesivir </span>
   <span class="font13">rhinopharyngeal </span>
   <span class="font13">swab </span>
   <span class="font13">therapy: </span>
   <span class="font13">{font-family </span>
   <span class="font12">China </span>
   <span class="font12">Clinical </span>
   <span class="font12">Feb </span>
   <span class="font12">Health </span>
   <span class="font12">charge </span>
   <span class="font12">diagnostics: </span>
   <span class="font12">dose, </span>
   <span class="font12">font-size </span>
   <span class="font12">intravenously </span>
   <span class="font12">mmHg </span>
   <span class="font12">monitoring </span>
   <span class="font12">new </span>
   <span class="font12">patient </span>
   <span class="font12">perform </span>
   <span class="font12">rapid </span>
   <span class="font12">rate, </span>
   <span class="font12">single </span>
   <span class="font12">specialist </span>
   <span class="font12">syndrome </span>
   <span class="font12">therapy </span>
   <span class="font12">use </span>
   <span class="font12">&amp;gt; </span>
   <span class="font12">China. </span>
   <span class="font12">Chloroquine </span>
   <span class="font12">IL- </span>
   <span class="font12">Infectious </span>
   <span class="font12">PCR </span>
   <span class="font12">Remdesivir </span>
   <span class="font12">Severe </span>
   <span class="font12">Tocilizumab </span>
   <span class="font12">according </span>
   <span class="font12">administration </span>
   <span class="font12">agents </span>
   <span class="font12">availability </span>
   <span class="font12">critical </span>
   <span class="font12">double; </span>
   <span class="font12">higher </span>
   <span class="font12">order </span>
   <span class="font11">"L. </span>
   <span class="font11">Acute </span>
   <span class="font11">Antiviral </span>
   <span class="font11">Coronavirus </span>
   <span class="font11">Disease </span>
   <span class="font11">European </span>
   <span class="font11">HIV </span>
   <span class="font11">Infect </span>
   <span class="font11">Institute </span>
   <span class="font11">Italy </span>
   <span class="font11">MEWS </span>
   <span class="font11">March </span>
   <span class="font11">Med </span>
   <span class="font11">PaO/FiO </span>
   <span class="font11">RT-PCR </span>
   <span class="font11">Treatment </span>
   <span class="font11">adverse </span>
   <span class="font11">antigen </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cases </span>
   <span class="font11">conditions </span>
   <span class="font11">distress </span>
   <span class="font11">drug </span>
   <span class="font11">drugs </span>
   <span class="font11">evaluated </span>
   <span class="font11">following </span>
   <span class="font11">high </span>
   <span class="font11">hospital </span>
   <span class="font11">increase </span>
   <span class="font11">infection. </span>
   <span class="font11">interactions </span>
   <span class="font11">loading </span>
   <span class="font11">parameters </span>
   <span class="font11">phosphate </span>
   <span class="font11">recent </span>
   <span class="font11">response </span>
   <span class="font11">risk </span>
   <span class="font11">sample </span>
   <span class="font11">score </span>
   <span class="font11">solid; </span>
   <span class="font11">starting </span>
   <span class="font11">suspected </span>
   <span class="font11">therapeutic </span>
   <span class="font11">virus </span>
   <span class="font11">visited </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(if </span>
   <span class="font11">(once/work </span>
   <span class="font11">Additional </span>
   <span class="font11">Berlin </span>
   <span class="font11">Characteristics: </span>
   <span class="font11">Chinese </span>
   <span class="font11">D-dimer, </span>
   <span class="font11">Dosage </span>
   <span class="font11">GPD </span>
   <span class="font11">Hydroxychloroquine </span>
   <span class="font11">Influenza </span>
   <span class="font11">OSI </span>
   <span class="font11">Oxygenation </span>
   <span class="font11">Patient </span>
   <span class="font11">Patients </span>
   <span class="font11">Periodic </span>
   <span class="font11">Prevention </span>
   <span class="font11">SARS-COV </span>
   <span class="font11">Strict </span>
   <span class="font11">Supportive </span>
   <span class="font11">Use </span>
   <span class="font11">action </span>
   <span class="font11">aimed </span>
   <span class="font11">antimicrobial </span>
   <span class="font11">assessment </span>
   <span class="font11">bold </span>
   <span class="font11">combination </span>
   <span class="font11">confirmed </span>
   <span class="font11">count </span>
   <span class="font11">courier; </span>
   <span class="font11">currently </span>
   <span class="font11">days. </span>
   <span class="font11">declared </span>
   <span class="font11">definition </span>
   <span class="font11">demonstrated </span>
   <span class="font11">described </span>
   <span class="font11">early </span>
   <span class="font11">em; </span>
   <span class="font11">exchange </span>
   <span class="font11">expert </span>
   <span class="font11">failure, </span>
   <span class="font11">fever </span>
   <span class="font11">goals </span>
   <span class="font11">heart </span>
   <span class="font11">improvement </span>
   <span class="font11">in-vitro </span>
   <span class="font11">inflammatory </span>
   <span class="font11">inhibiting </span>
   <span class="font11">involvement. </span>
   <span class="font11">limited </span>
   <span class="font11">lower </span>
   <span class="font11">microbiologic </span>
   <span class="font11">mild </span>
   <span class="font11">moderate </span>
   <span class="font11">multiplex </span>
   <span class="font11">negative </span>
   <span class="font11">persistently </span>
   <span class="font11">person </span>
   <span class="font11">pneumonia </span>
   <span class="font11">pneumonia. </span>
   <span class="font11">presenting </span>
   <span class="font11">procedures </span>
   <span class="font11">pt;} </span>
   <span class="font11">pulmonary </span>
   <span class="font11">radiological </span>
   <span class="font11">recommended </span>
   <span class="font11">release </span>
   <span class="font11">required </span>
   <span class="font11">samples </span>
   <span class="font11">second </span>
   <span class="font11">serology </span>
   <span class="font11">specific </span>
   <span class="font11">stage </span>
   <span class="font11">suggesting </span>
   <span class="font11">test </span>
   <span class="font11">tract </span>
   <span class="font11">trials </span>
   <span class="font11">using </span>
   <span class="font11">vital </span>
  </p>
 </body>
</html>
